• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于MRI的头颈癌患者预后放射性组学模型开发的方法与技术

Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients.

作者信息

Bologna Marco, Corino Valentina, Tenconi Chiara, Facchinetti Nadia, Calareso Giuseppina, Iacovelli Nicola, Cavallo Anna, Alfieri Salvatore, Cavalieri Stefano, Fallai Carlo, Valdagni Riccardo, Rancati Tiziana, Trama Annalisa, Licitra Lisa, Orlandi Ester, Mainardi Luca

出版信息

Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1152-1155. doi: 10.1109/EMBC44109.2020.9176565.

DOI:10.1109/EMBC44109.2020.9176565
PMID:33018191
Abstract

The purpose of this study was to establish a methodology and technology for the development of an MRI-based radiomic signature for prognosis of overall survival (OS) in nasopharyngeal cancer from non-endemic areas. The signature was trained using 1072 features extracted from the main tumor in T1-weighted and T2-weighted images of 142 patients. A model with 2 radiomic features was obtained (RAD model). Tumor volume and a signature obtained by training the model on permuted survival data (RADperm model) were used as a reference. A 10-fold cross-validation was used to validate the signature. Harrel's C-index was used as performance metric. A statistical comparison of the RAD, RADperm and volume was performed using Wilcoxon signed rank tests. The C-index for the RAD model was higher compared to the one of the RADperm model (0.69±0.08 vs 0.47±0.05), which ensures absence of overfitting. Also, the signature obtained with the RAD model had an improved C-index compared to tumor volume alone (0.69±0.08 vs 0.65±0.06), suggesting that the radiomic signature provides additional prognostic information.

摘要

本研究的目的是建立一种方法和技术,用于开发基于磁共振成像(MRI)的影像组学特征,以预测非流行地区鼻咽癌的总生存期(OS)。使用从142例患者的T1加权和T2加权图像中的主要肿瘤提取的1072个特征对该特征进行训练。获得了一个具有2个影像组学特征的模型(RAD模型)。将肿瘤体积和通过对置换生存数据训练该模型获得的特征(RADperm模型)用作参考。采用10倍交叉验证来验证该特征。使用Harrel's C指数作为性能指标。使用Wilcoxon符号秩检验对RAD、RADperm和体积进行统计比较。与RADperm模型相比,RAD模型的C指数更高(0.69±0.08对0.47±0.05),这确保了不存在过拟合。此外,与单独的肿瘤体积相比,RAD模型获得的特征具有更高的C指数(0.69±0.08对0.65±0.06),表明影像组学特征提供了额外的预后信息。

相似文献

1
Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients.基于MRI的头颈癌患者预后放射性组学模型开发的方法与技术
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1152-1155. doi: 10.1109/EMBC44109.2020.9176565.
2
Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset.头颈部癌症预后放射组学特征:基于多中心 MRI 数据集的建立和验证。
Radiother Oncol. 2023 Jun;183:109638. doi: 10.1016/j.radonc.2023.109638. Epub 2023 Mar 31.
3
Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.基于 MRI 影像组学特征对头颈部鳞状细胞癌的预后预测。
Eur Radiol. 2020 Nov;30(11):6311-6321. doi: 10.1007/s00330-020-06962-y. Epub 2020 Jun 4.
4
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.基于治疗前磁共振成像(MRI)的放射组学分析对有效治愈的头颈部鳞状细胞癌(HNSCC)患者的预后作用。
Acta Oncol. 2021 Sep;60(9):1192-1200. doi: 10.1080/0284186X.2021.1924401. Epub 2021 May 26.
5
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.基线MRI影像组学可预测非地方性EB病毒相关鼻咽癌患者的总生存期。
Cancers (Basel). 2020 Oct 13;12(10):2958. doi: 10.3390/cancers12102958.
6
MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.基于 MRI 的放射组学特征作为头颈部鳞状细胞癌患者的预测标志物。
Eur J Radiol. 2019 Aug;117:193-198. doi: 10.1016/j.ejrad.2019.06.019. Epub 2019 Jun 25.
7
Vulnerabilities of radiomic signature development: The need for safeguards.放射组学特征开发的脆弱性:需要采取保障措施。
Radiother Oncol. 2019 Jan;130:2-9. doi: 10.1016/j.radonc.2018.10.027. Epub 2018 Nov 8.
8
Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.影像组学特征:一种基于磁共振成像的颅底脊索瘤新型预后生物标志物。
Radiother Oncol. 2019 Dec;141:239-246. doi: 10.1016/j.radonc.2019.10.002. Epub 2019 Oct 25.
9
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.基于MRI的局部晚期口腔鳞状细胞癌的放射组学预后特征:开发、测试及与基因组预后特征的比较
Biomark Res. 2023 Jul 16;11(1):69. doi: 10.1186/s40364-023-00494-5.
10
Radiomic signature of F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits.基于氟[18F]脱氧葡萄糖 PET/CT 的影像组学特征预测胃癌患者生存和化疗获益
Theranostics. 2018 Nov 12;8(21):5915-5928. doi: 10.7150/thno.28018. eCollection 2018.

引用本文的文献

1
Repeatability and prognostic value of radiomic features: a study in esophageal cancer and nasopharyngeal carcinoma.放射组学特征的可重复性及预后价值:一项针对食管癌和鼻咽癌的研究
Insights Imaging. 2025 Aug 2;16(1):166. doi: 10.1186/s13244-025-02044-z.
2
Computational analysis of variability and uncertainty in the clinical reference on magnetic resonance imaging radiomics: modelling and performance.磁共振成像放射组学临床参考中变异性和不确定性的计算分析:建模与性能
Vis Comput Ind Biomed Art. 2024 Nov 19;7(1):28. doi: 10.1186/s42492-024-00180-9.
3
Radiomics feature reliability assessed by intraclass correlation coefficient: a systematic review.
通过组内相关系数评估的影像组学特征可靠性:一项系统评价
Quant Imaging Med Surg. 2021 Oct;11(10):4431-4460. doi: 10.21037/qims-21-86.
4
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.基线MRI影像组学可预测非地方性EB病毒相关鼻咽癌患者的总生存期。
Cancers (Basel). 2020 Oct 13;12(10):2958. doi: 10.3390/cancers12102958.